Table 3 |
|||||
|
Correlation between ERα status of primary tumour and heterogeneity of ERα expression in patients with more than one disseminated tumour cell (DTC). |
|||||
| ERα status |
DTC |
Total (%) |
|||
|
|
|||||
| ERα + (%) |
ERα – (%) |
ERα + (%) & - (%) |
|||
|
|
|||||
| Tumour |
ERα – (%) |
0 |
7 (18) |
0 |
7 (18) |
| ERα + (%) |
0 |
21 (55) |
10 (26) |
31 (82) |
|
|
|
|||||
| Total (%) |
0 |
28 (74) |
10 (26) |
38 (100) |
|
|
|
|||||
|
*p = 0.3 (Fisher-exact-test, two-sided). ER = oestrogen receptor.; + = positive; - = negative. |
|||||
|
Fehm et al. Breast Cancer Research 2008 10:R76 doi:10.1186/bcr2143 |
|||||
